IP Library Granted Patent US 7,057,031
Granted Patent B2
US 7,057,031 · App. 10/193,781 · Granted Jun 6, 2006

Nucleotide compositions comprising photocleavable markers and methods of preparation thereof

Assignee: AmberGen, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,057,031
App. No.
10/193,781
Granted
Jun 6, 2006
Kind
B2
Abstract

Labelled nucleotides and polynucleotides useful in the sequencing of nucleic acids are described. Methods of preparing photocleavable marker nucleotides and photocleavable marker-polynucleotide conjugates are described. Such photocleavable markere nucleotides can be incorporated into nucleic acid so as to create photocleavable marker-polynucleotide conjugates.

Claims (16)

1. A method of preparing a marker-photocleavable linker-nucleotide conjugate comprising:

a) providing i) a photocleavable linker comprising a protective group, ii) an amino-nucleotide analog, and iii) an activated marker molecule selected from the group consisting of BODIPY-FL-SF and Cy5-NHS;

b) operably linking said photocleavable linker to said amino-nucleotide analog to produce a photocleavable linker-nucleotide conjugate;

c) removing said protective group from said photocleavable linker-nucleotide conjugate under conditions such that an activated photocleavable linker-nucleotide conjugate is created, wherein said activated photocleavable linker-nucleotide conjugate has an exposed reactive site on the linker portion of the conjugate; and

d) contacting said activated marker molecule with said activated photocleavable linker-nucleotide conjugate under conditions such that a marker-photocleavable linker-nucleotide conjugate is produced.

2. The method of claim 1 , wherein said protective group is selected from the group consisting of Fmoc and Bpoc.

3. The method of claim 1 , wherein said amino-nucleotide analog is 5-(3-aminoallyl)-2′-deoxyuridine 5′-triphosphate.

4. The method of claim 1 further comprising: p 1 e) contacting said marker-photocleavable linker-nucleotide conjugate of step (d) with a modifying enzyme, in the presence of nucleic acid, under conditions such that said marker-photocleavable linker-nucleotide conjugate is incorporated into said nucleic acid to produce a labeled nucleic acid.

5. The method of claim 4 , further comprising f) detecting said incorporated marker of said marker-photocleavable linker-nucleotide conjugate in said labeled nucleic acid.

6. The method of claim 5 , further comprising, prior to step f), the step of separating unincorporated marker-photocleavable linker-nucleotide coiijugate from said labeled nucleic acid.

7. The method of claim 4 , further comprising the step of removing the incorporated photocleavable marker from said labeled nucleic acid by exposing said labeled nucleic acid to electromagnetic radiation so as to create a treated nucleic acid.

8. The method of claim 7 , further comprising subjecting said treated nucleic acid to a further subsequent labeling reaction with a different marker-photocleavable linker-nucleotide conjugate after said removing step.

9. The method of claim 4 , wherein said nucleic acid-modifying enzyme is a terminal deoxynucleotidyl transferase.

10. The marker-photocleavable linker-nucleotide conjugate produced according to claim 1 .

11. A marker-photocleavable linker-nucleotide conjugate of the structure:

wherein F is a fluorophore marker and PPP is:

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2002
From: OLEJNIK, JERZY; KRZYMANSKA-OLEJNIK, EDYTA; ROTHSCHILD, KENNETH J.
To: AMBERGEN, INC.
Reel/Frame 013319/0464 →
Continuity (2)
Provisional Application 6030549000 · Jul 13, 2001
Related Publication 20030099972A1 · May 29, 2003